Marc Laterriere-Giry

Darlinghurst, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

Journal: Nature communications
Published: March 26, 2018

'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.

'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.

Journal: Oncogene
Published: October 25, 2016

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.

Journal: Science translational medicine
Published: September 06, 2016

Hypermutation In Pancreatic Cancer.

Hypermutation In Pancreatic Cancer.

Journal: Gastroenterology
Published: January 29, 2016

Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions.

Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions.

Journal: Oncotarget
Published: November 27, 2015

Genomic analyses identify molecular subtypes of pancreatic cancer.

Genomic analyses identify molecular subtypes of pancreatic cancer.

Journal: Nature
Published: May 03, 2015

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas.

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas.

Journal: Current cancer drug targets
Published: February 09, 2015

Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Journal: International journal of molecular sciences
Published: January 15, 2015

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.

Journal: Oncogene
Published: December 22, 2014

Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia.

Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia.

Journal: PloS one
Published: December 18, 2014

Whole genomes redefine the mutational landscape of pancreatic cancer.

Whole genomes redefine the mutational landscape of pancreatic cancer.

Journal: Nature
Published: May 24, 2014

SOX9 regulates ERBB signalling in pancreatic cancer development.

SOX9 regulates ERBB signalling in pancreatic cancer development.

Journal: Gut
Published: February 20, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026